Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
シアトル
+1 415 439 1799シアトル
Capabilities
Suggested News & Insights
EU Pharma Package: Sharp New Tools With Limited ProtectionsDecember 18, 2025EU Biotech Act: EU Proposes First Set of Rules to Facilitate Biopharmaceutical CompetitivenessThursday, December 18, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory